Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and ... Show More
Yesterday
SOTS 2nd Hour: Jones Act Waiver, Iran Market Latest, & LIVE: Docusign CEO 3/18/26
Top of the hour: President Trump waiving a U.S. shipping law for 60 days to steady oil markets... but not helping prices or markets in the early trade. Carl Quintanilla, David Faber, and Michael Santoli broke down the news before turning to longtime market veteran and Evercore st ... Show More
44 m
Yesterday
Fed Decision Day, Hot PPI and Oil Prices Weigh on Stocks, Jensen Huang on "The Next ChatGPT" 3/18/26
Carl Quintanilla, Jim Cramer and David explored rising oil prices and hotter-than-expected February PPI being a double whammy for stocks. Wall Street awaits Wednesday's Fed decision on rates — and what the accompanying statement might say about inflation in wake of the Iran war. ... Show More
43m 7s
Jan 2025
AI, vaccine distrust, and the future of healthcare: Novartis CEO
Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline i ... Show More
25m 45s